PROFUND ADVISORS LLC

Position in VERA — Vera Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in VERA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,590,330

-$239,008 QoQ

Shares Held

37,062

-18.5% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#102

of 217 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. VERA ranks #37 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,590,330	37,062	-18.5%	Shares	Sole	2026-08-11
2026-03-31	$1,829,338	45,472	+42.0%	Shares	Sole	2026-04-27
2025-12-31	$1,621,695	32,024	+68.6%	Shares	Sole	2026-02-06
2025-09-30	$551,907	18,992	+24.3%	Shares	Sole	2025-11-06
2025-06-30	$360,020	15,281	-13.4%	Shares	Sole	2025-08-07
2025-03-31	$423,784	17,643	+3.2%	Shares	Sole	2025-05-08
2024-12-31	$722,778	17,091	+8.5%	Shares	Sole	2025-02-14
2024-09-30	$695,973	15,746	-29.7%	Shares	Sole	2024-11-14
2024-06-30	$810,287	22,396	-18.1%	Shares	Sole	2024-08-13
2024-03-31	$1,179,159	27,346	-1.5%	Shares	Sole	2024-05-08
2023-12-31	$427,087	27,769	+20.1%	Shares	Sole	2024-02-14
2023-09-30	$316,892	23,114	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.